Jan 31 (Reuters) - Prana Biotechnology Ltd (PBT) :
- PRANA RECEIVES FIRST ORPHAN DRUG DESIGNATION FROM THE FDA FOR THE TREATMENT OF MULTIPLE SYSTEM ATROPHY
- PRANA BIOTECHNOLOGY LTD - PRANA IS CONDUCTING A PHASE 1 CLINICAL TRIAL OF PBT434 AND EXPECTS IT TO BE COMPLETED THIS YEAR